Amyloid Network Topology Characterizes the Progression of Alzheimer’s Disease During the Predementia Stages

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 09, 2017
Source ID
10.1093/cercor/bhx294

Entities

People

  • Danielle Van Westen
  • Eric Westman
  • For The Alzheimer’s Disease Neuroimaging Initiative*
  • Giovanni Volpe
  • Joana B. Pereira
  • Oskar Hansson
  • Sebastian Palmqvist
  • Tor Olof Strandberg

Organizations

  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eli Lilly and Company
  • European Research Council
  • GE HealthCare
  • Hjärnfonden
  • Hoffmann-La Roche
  • Johnson & Johnson Pharmaceutical Research and Development
  • Karolinska Institutet
  • Laboratoires Servier
  • Lund University
  • Medpace
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Northern California Institute for Research and Education
  • Pfizer
  • Roche (United States)
  • Skåne University Hospital
  • Swedish Foundation for Strategic Research
  • Swedish Research Council
  • Takeda Pharmaceutical Company
  • University of Gothenburg
  • Åke Wibergs Stiftelse